These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

84 related articles for article (PubMed ID: 17130548)

  • 41. Ursolic acid enhances the cellular immune system and pancreatic beta-cell function in streptozotocin-induced diabetic mice fed a high-fat diet.
    Jang SM; Yee ST; Choi J; Choi MS; Do GM; Jeon SM; Yeo J; Kim MJ; Seo KI; Lee MK
    Int Immunopharmacol; 2009 Jan; 9(1):113-9. PubMed ID: 19013541
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Role of inflammatory cytokines and chemoattractants in the rat model of streptozotocin-induced diabetic heart failure.
    Drimal J; Knezl V; Navarova J; Nedelcevova J; Paulovicova E; Sotnikova R; Snirc V; Drimal D
    Endocr Regul; 2008 Sep; 42(4):129-35. PubMed ID: 18999900
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Comparison of successful and unsuccessful islet/Sertoli cell cotransplant grafts in streptozotocin-induced diabetic mice.
    Dufour JM; Lord SJ; Kin T; Rayat GR; Dixon DE; Bleackley RC; Korbutt GS; Rajotte RV
    Cell Transplant; 2008; 16(10):1029-38. PubMed ID: 18351019
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Ganglioside therapy of type I diabetes: enhancement of hyperglycemia in the low dose streptozotocin model.
    Zielasek J; Kolb H
    Life Sci; 1992; 51(1):49-52. PubMed ID: 1535407
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Low dose streptozotocin-induced diabetes in mice: reduced IL-2 production and modulation of streptozotocin-induced hyperglycemia by IL-2.
    Burkart V; Zielasek J; Kantwerk-Funke G; Hibbe T; Schwab E; Kolb H
    Int J Immunopharmacol; 1992 Aug; 14(6):1037-44. PubMed ID: 1428358
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Antihyperglycemic effect of 18 beta-glycyrrhetinic acid, aglycone of glycyrrhizin, on streptozotocin-diabetic rats.
    Kalaiarasi P; Pugalendi KV
    Eur J Pharmacol; 2009 Mar; 606(1-3):269-73. PubMed ID: 19374864
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Effect of early insulin therapy on nuclear factor kappaB and cytokine gene expressions in the liver and skeletal muscle of high-fat diet, streptozotocin-treated diabetic rats.
    Bi Y; Sun WP; Chen X; Li M; Liang H; Cai MY; Zhu YH; He XY; Xu F; Weng JP
    Acta Diabetol; 2008 Sep; 45(3):167-78. PubMed ID: 18500427
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Simvastatin protects against multiple low-dose streptozotocin-induced type 1 diabetes in CD-1 mice and recurrence of disease in nonobese diabetic mice.
    Rydgren T; Vaarala O; Sandler S
    J Pharmacol Exp Ther; 2007 Oct; 323(1):180-5. PubMed ID: 17636011
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Interleukin-1 and IL-23 induce innate IL-17 production from gammadelta T cells, amplifying Th17 responses and autoimmunity.
    Sutton CE; Lalor SJ; Sweeney CM; Brereton CF; Lavelle EC; Mills KH
    Immunity; 2009 Aug; 31(2):331-41. PubMed ID: 19682929
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Clioquinol attenuates zinc-dependent beta-cell death and the onset of insulitis and hyperglycemia associated with experimental type I diabetes in mice.
    Priel T; Aricha-Tamir B; Sekler I
    Eur J Pharmacol; 2007 Jun; 565(1-3):232-9. PubMed ID: 17434477
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Autoimmune inflammation from the Th17 perspective.
    Furuzawa-Carballeda J; Vargas-Rojas MI; Cabral AR
    Autoimmun Rev; 2007 Jan; 6(3):169-75. PubMed ID: 17289553
    [TBL] [Abstract][Full Text] [Related]  

  • 52. A positive feedback loop of IL-21 signaling provoked by homeostatic CD4+CD25- T cell expansion is essential for the development of arthritis in autoimmune K/BxN mice.
    Jang E; Cho SH; Park H; Paik DJ; Kim JM; Youn J
    J Immunol; 2009 Apr; 182(8):4649-56. PubMed ID: 19342640
    [TBL] [Abstract][Full Text] [Related]  

  • 53. IL-21 and IL-21R are not required for development of Th17 cells and autoimmunity in vivo.
    Sonderegger I; Kisielow J; Meier R; King C; Kopf M
    Eur J Immunol; 2008 Jul; 38(7):1833-8. PubMed ID: 18546146
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Prevention of murine experimental autoimmune orchitis by recombinant human interleukin-6.
    Li L; Itoh M; Ablake M; Macrì B; Bendtzen K; Nicoletti F
    Clin Immunol; 2002 Feb; 102(2):135-7. PubMed ID: 11846454
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Induction of insulin-dependent diabetes by streptozotocin. Inhibition by estrogens and potentiation by androgens.
    Paik SG; Michelis MA; Kim YT; Shin S
    Diabetes; 1982 Aug; 31(8 Pt 1):724-9. PubMed ID: 6219020
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Improvements needed in reporting the methodology for STZ-induced diabetes in rats.
    Yanni AE; Antoniou N; Kostomitsopoulos N
    Am J Physiol Endocrinol Metab; 2021 May; 320(5):E898-E899. PubMed ID: 33900124
    [No Abstract]   [Full Text] [Related]  

  • 57. Natural and therapy-induced antibodies to cytokines.
    Bendtzen K
    Drug Discov Today; 2004 Mar; 9(6):259. PubMed ID: 15003242
    [No Abstract]   [Full Text] [Related]  

  • 58. An introduction to the special issue on "cytokines and autoimmune diseases".
    Kalvakolanu DV
    J Interferon Cytokine Res; 2011 Oct; 31(10):693-4. PubMed ID: 21861698
    [No Abstract]   [Full Text] [Related]  

  • 59. The interleukins in acquired disease.
    Malkovský M; Sondel PM; Strober W; Dalgleish AG
    Clin Exp Immunol; 1988 Nov; 74(2):151-61. PubMed ID: 3066538
    [No Abstract]   [Full Text] [Related]  

  • 60. [Present status and future aspects of clinical use of cytokines].
    Takaku F
    Nihon Rinsho; 1992 Aug; 50(8):1703-7. PubMed ID: 1433955
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.